Articles by Moritake Iguchi

What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation?

Maki Komiyama, Moritake Iguchi, Hiromichi Wada, et al

Published:

Citation: European Cardiology Review 2024;19:e10.

DOI:

https://doi.org/10.15420/ecr.2023.50
When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention

Moritake Iguchi, Hiromichi Wada, Felipe Martínez, et al

Published:

Citation: European Cardiology Review 2023;18:e41.

DOI:

https://doi.org/10.15420/ecr.2022.62
Relationship Between VEGF-C Levels and Mortality in Patients with Peripheral Artery Disease

Nobutoyo Masunaga, Shuichi Ura, Mitsuru Ishii, et al

Citation: European Cardiology Review 2018;13(2):123.

DOI:

https://doi.org/10.15420/ecr.2018.13.2.PO4
VEGF-C and Cardiovascular Mortality in Patients Undergoing Drug-eluting Stent Implantation

Takashi Unoki, Shuichi Ura, Daisuke Takagi, et al

Citation: European Cardiology Review 2018;13(2):124.

DOI:

https://doi.org/10.15420/ecr.2018.13.2.PO5
Relationship Between VEGF-C Levels and All-cause Mortality in Patients with Chronic Heart Failure

Moritake Iguchi, Shuichi Ura, Nobutoyo Masunaga, et al

Citation: European Cardiology Review 2018;13(2):129.

DOI:

https://doi.org/10.15420/ecr.2018.13.2.PO10